Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001765581-25-000080
Filing Date
2025-08-11
Accepted
2025-08-11 17:36:09
Documents
1
Period of Report
2025-08-07

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgardoc.html 4  
1 PRIMARY DOCUMENT edgardoc.xml 4 4981
  Complete submission text file 0001765581-25-000080.txt   6694
Mailing Address FIFTH FLOOR, WATERLOO EXCHANGE WATERLOO ROAD DUBLIN Ireland D04 E5W7
Business Address FIFTH FLOOR, WATERLOO EXCHANGE WATERLOO ROAD DUBLIN Ireland D04 E5W7 353-1-634-7800
Jazz Pharmaceuticals plc (Issuer) CIK: 0001232524 (see all company filings)

EIN.: 981032470 | State of Incorp.: L2 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O TELADOC HEALTH, INC. 2 MANHATTANVILLE ROAD, SUITE 203 PURCHASE NY 10577
Business Address
Smith Mark Douglas (Reporting) CIK: 0001756253 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33500 | Film No.: 251203206